Medtronic (MDT) Q1 FY27 — revenue $9.8B (+13.7% Y/Y organic) beats; non-GAAP EPS <meta name="viewport" content="width=device-width, initial-scale=1.0" />.45 (+15.1% Y/Y) tops guide; GAAP EPS <meta name="viewport" content="width=device-width, initial-scale=1.0" />.14 (+40.7%); FY27 organic revenue guide raised to 7.25–7.75% and non-GAAP EPS to $5.94–$6.00; MDT trades higher on Tuesday Sept 1

.45 beats, and FY27 guide goes up on both lines." /> .45 (+15.1% Y/Y) tops guide; GAAP EPS .14 (+40.7%); FY27 organic revenue guide raised to 7.25–7.75% and non-GAAP EPS to $5.94–$6.00; MDT trades higher on Tuesday Sept 1" /> .45 beats, and FY27 guide goes up on both lines." /> .45 (+15.1% Y/Y) tops guide; GAAP EPS .14 (+40.7%); FY27 organic revenue guide raised to 7.25–7.75% and non-GAAP EPS to $5.94–$6.00; MDT trades higher on Tuesday Sept 1" /> .45 beats, and FY27 guide goes up on both lines." />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.